Latest News

SwedenBIO executive dinner 2021 – Guldbio-galan

Malin Hultqvist Hopkins (CEO) and Nina Woodworth (COO) have attended the 2021 years edition of the SwedenBIO Executive Dinner taking place at Winterviken in Stockholm. The glamorous gala provided a long missed opportunity to meet and interact with life science industry colleagues. Thanks to SwedenBIO for organising such a great event.

Read more

Redoxis in collaborative project to study inflammation in vascular disease

We are happy to announce that Redoxis AB is a partner in a research project called “Targeting he melanocortin system as a novel strategy to reduce inflammation during vascular disease” led by Senior Lecturer Liza Ljungberg, School of Medical Sciences at Örebro University. The project was funded by a research grant of SEK 4 million […]

Read more

Redoxis is once again accredited for CIR (French Research Tax Reduction)

Redoxis has been granted approval for the French research tax credit (CIR) for 2021, 2022 and 2023 from the French Ministry of Higher Education and Research. This R&D tax credit makes it possible for eligible French research companies to claim tax relief on costs of R&D services outsourced to Redoxis.

Read more

We are increasing our In Vitro service capacity

This week we are welcoming Linda Reimer Rasmusson back to Redoxis. Linda started her carreer at Redoxis and is now returning to strengthen our In Vitro service capacity. During the last years, Linda has held positions in both R&D and service providing companies and with her profound experience in In Vitro assays she will add […]

Read more

Welcome Tekla!

The newest addition to our team is Tekla Franzén. Tekla is a trained animal technician and held her the most recent position at the Lund University animal facility. Teklas competence, experience and positive attitude will be a great asset to team and we are very happy to have Tekla aboard!

Read more